🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to learn about the interaction of sis...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2018-11-07
Trial ID
NCT03782662
Treatments Being Tested
The purpose of the study is to assess the effects of rifampin on the pharma...
Status
Terminated
Location
Ppd Development
Start Date
2010-03
Trial ID
NCT01068756
Treatments Being Tested
Open-label, parallel, 2-arm, fixed-sequence study to investigate the effect...
Status
Completed
Location
QPS Missouri
Start Date
2020-10-24
Trial ID
NCT04606537
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
The main aim of this study is to check how rifampin affects the way soticle...
Status
Completed
Location
Celerion
Start Date
2021-11-22
Trial ID
NCT05098041
Treatments Being Tested
The current study is designed to estimate the effect of rifampin (600 mg or...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-09
Trial ID
NCT01204112
Treatments Being Tested
The purpose of this study is to estimate the effect of multiple doses of Ri...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01147055
Treatments Being Tested
There is a rapidly-growing need to identify evidence-based, safe, and effec...
Status
Terminated
Location
Hospital Nossa Senhora da Conceicao CRS (12201)
Start Date
2013-07-13
Trial ID
NCT01601626
Non-inferiority trial to determine whether partial oral treatment is non-in...
Status
Recruiting
Location
Hospital General de Alicante
Start Date
2022-08-17
Trial ID
NCT05398679
Treatments Being Tested
NTM therapy consists of a multi-drug macrolide based regimen for 18-24 mont...
Status
Completed
Location
Loma Linda University Medical Center
Start Date
2019-02-22
Trial ID
NCT03672630
Treatments Being Tested